HOME >> BIOLOGY >> NEWS
A gene that protects from kidney disease

Researchers from the European Molecular Biology Laboratory (EMBL) and the University of Michigan have discovered a gene that protects us against a serious kidney disease. In the current online issue of Nature Genetics they report that mutations in the gene cause nephronopthisis (NPHP) in humans and mice. NPHP is a disease marked by kidney degeneration during childhood that leads to kidney failure requiring organ transplantation. The insights might help develop effective, noninvasive therapies.

The kidneys are the organs that help our body dispose of potentially harmful waste. Diseases that affect this fundamental function are very serious but so far only poorly understood. NPHP is such a disease; it causes the kidneys to degenerate and shrink starting early on in childhood often leading to renal failure before the age of 30. So far, kidney transplantation in early age has been the only way to save patients suffering from NPHP. With a new mouse model Mathias Treier and his group at EMBL have shed new light on the molecular mechanisms underlying NPHP opening up novel ways to treat the disease.

Our mice show striking similarities with NPHP patients, says Mathias Treier, group leader at EMBL. Very early on in their lives their kidney cells start to die and the mice develop all the characteristic disease symptoms. It is the first time that a mouse model reveals increased cell death as the mechanism underpinning kidney degeneration in NPHP. The genetic cause is a mutation in a gene called GLIS2.

GLIS2 normally prevents cell death in the adult kidney. It does so by shutting down genes that initiate cell death and that are only required during the development of the organ. A mutation interfering with GLIS2 function reactivates these harmful genes the result being that large numbers of kidney cells die. The organ shrinks and changes in its architecture occur which affect normal kidney function.

To find out if GLIS2 has the same effe
'"/>

Contact: Anna-Lynn Wegener
wegener@embl.de
49-622-138-7452
European Molecular Biology Laboratory
8-Jul-2007


Page: 1 2

Related biology news :

1. Reading ability protects brain from lead exposure
2. Research shows NPD1 protects a key component of vision
3. Drug protects brain cells in Huntingtons disease model, researchers find
4. PINK1 protects from Parkinsons
5. Enzyme delivered in smaller package protects cells from radiation damage
6. Parkinsons protein protects neurons from stress induced cell death
7. Caspase-14 protects our skin against UVB and dehydration
8. Reproductive speed protects large animals from being hunted to extinction
9. Molecule that destroys bone also protects it, new research shows
10. Peramivir protects mice from lethal H5N1 infection
11. Estrogen protects liver after traumatic injury

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/30/2020)... Calif. (PRWEB) , ... May 29, 2020 , ... ... enabler of digital transformation for enterprises globally, has collaborated with EchoNous Inc. to ... FDA. It can measure systolic heart function, which has been clinically tested ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... R&D, today announced that Gritstone Oncology, Inc., a clinical-stage biotechnology company developing ... engagers and TCR-based therapeutics, has implemented Genedata Biologics ® within their ...
(Date:5/21/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... May 20, 2020 , ... ... justice, and remove danger for all of us. The positions of these men and ... as from the defense for not following rules precisely. Officers have always had to ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... May 12, 2020 , ... ... research, is bringing together thousands of industry leaders, clinicians, research scientists, medical professionals ... plenary speakers, Carl June, MD, Director of the Center for Cellular Immunotherapies at ...
(Date:5/5/2020)... ... ... ProductLife Group has marked the next phase in its global ... years at Altran, where he was Group VP of Life Sciences and Head of ... Xavier was involved in his early career in the development of new medical devices ...
(Date:4/22/2020)... CAMBRIDGE, Mass. (PRWEB) , ... April 20, 2020 ... ... with US offices in Cambridge, MA, announced today that Omixon’s founder and chairman ... early commercialisation of Omixon’s flagship product Holotype HLA since 2014 before stepping into ...
(Date:4/7/2020)... ... April 06, 2020 , ... ... the life sciences industry, has announced the release of at-home virtual learning resources ... priority is the health and safety of our employees as we continue to ...
Breaking Biology Technology:
Cached News: